How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis
Volume: 49, Issue: 1, Pages: 45 - 62
Published: Mar 1, 2020
Abstract
Non-alcoholic fatty liver disease (NAFLD) figures prominently into the clinical hepatology landscape. NAFLD represents a disease spectrum comprising simple steatosis, steatosis with elevated liver enzymes, and non-alcoholic steatohepatitis (NASH), the entity with clear potential for fibrosis progression. Risk factors associated with fibrosis progression in NASH include histologic findings of lobular inflammation and any fibrosis as well as...
Paper Details
Title
How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis
Published Date
Mar 1, 2020
Volume
49
Issue
1
Pages
45 - 62
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History